Marshall Wace North America’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-23,230
| Closed | -$83K | – | 2066 |
|
|
2018
Q4 | $83K | Sell |
23,230
-514,598
| -96% | -$1.84M | ﹤0.01% | 1125 |
|
|
2018
Q3 | $3.08M | Buy |
537,828
+122,328
| +29% | +$701K | 0.02% | 407 |
|
|
2018
Q2 | $2.08M | Sell |
415,500
-207,387
| -33% | -$1.04M | 0.01% | 753 |
|
|
2018
Q1 | $3.2M | Sell |
622,887
-5,357
| -0.9% | -$27.5K | 0.02% | 677 |
|
|
2017
Q4 | $3.78M | Hold |
628,244
| – | – | 0.02% | 661 |
|
|
2017
Q3 | $3.77M | Sell |
628,244
-4,575
| -0.7% | -$27.4K | 0.02% | 626 |
|
|
2017
Q2 | $3.16M | Buy |
632,819
+189,350
| +43% | +$947K | 0.02% | 622 |
|
|
2017
Q1 | $2.22M | Buy |
+443,469
| New | +$2.22M | 0.02% | 560 |
|